/
/
/

Kilitch Drugs (India) Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)187.00
Volume (₹)28,652.00
High (₹)194.00
Upper Circuit195.26
Low (₹)185.00
Lower Circuit176.68
Prev Close185.97
52W High (₹)219.50
Price190.95
52W Low (₹)117.25

Share Market Cap & Key Ratios Overview

M.Cap (₹)653.43 Cr
Div. Yield (%)0.00
PE Ratio21.74
Debt to Equity0.32
Price to Book1.60
Book Value79.89
EPS (TTM)8.60
Face Value10.00
ROE (%)12.26

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
MANKINDNSE
KILITCH-BENSE
LTP
1W Low
1W High
Market cap (₹)
1835-5 (-0.27%)
1828
1856.80
4,41,957Cr
9198-124 (-1.33%)
9118.50
9415
2,47,576Cr
4850-115.5 (-2.33%)
4837.50
4988
1,89,233Cr
1099-20.1 (-1.80%)
1099
1135.50
1,11,671Cr
1351-15 (-1.10%)
1347.70
1373
1,10,273Cr
1926.9-42.1 (-2.14%)
1915.60
1981.80
1,06,460Cr
1145-20.5 (-1.76%)
1130
1182
96,906Cr
1660-19.8 (-1.18%)
1642.10
1688
96,402Cr
2063.2-31.8 (-1.52%)
2049.50
2108.50
95,843Cr
2280.5+0.5 (0.02%)
2222
2300.90
94,050Cr
190.95+4.98 (2.68%)
180
194
653Cr

Key Highlights of Kilitch Drugs (India) Ltd Balance Sheet

Kilitch Drugs (India) Ltd balance sheet discloses shareholders' funds of ₹34.96Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹34.96Cr, and the reserves and surplus of the company is ₹297.69Cr.

The company has its non-current liabilities with total liabilities of ₹494.88Cr as of 2026-03-31.

The current liabilities are ₹107.17Cr as of 2026-03-31. At the same time, current assets are ₹206.14Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹71.89Cr and tangible assets of ₹19.54Cr, provided in the Kilitch Drugs (India) Ltd financial statements.